Johnson & Johnson (JNJtedsarcade.US) rose more than 3%tedsarcade, reported 148tedsarcade.96 dollars. In the news, Johnson & Johnson announced that its subsidiary LLT Management LLC proposedtedsarcadeA reorganization plan to fully and finally resolve all ovarian cancer-related claims in current and future talc lawsuits filed against the company and its U.S. affiliates, which promises the company to pay claimants a present value of approximately $6.475 billion in damages over 25 years.
